1-17 of 17 results for member:"Patsy Calton"
Librarians' tools
- Search time
- 0.279 seconds
- Solr query time
- 0.003 seconds
- Search query
- member:"Patsy Calton"
- We searched for
- member_ses:299527
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
That this House believes a significant lack of education is allowing healthcare professionals and patients alike to become confused as to the best and most effective use of blood glucose monitoring for diabetes and that because the current primary care trust guidelines discourage the prescription of blood glucose strips for self-monitoring, it may become difficult for those in primary care to meet the National Institute for Clinical Excellence-recommended blood glucose target levels; and calls on Her Majesty's Government to ensure that blood glucose monitoring strips are not restricted for type II diabetes patients who are best placed to self-manage their condition.
That this House believes a significant lack of education is allowing healthcare professionals and patients alike to become confused as to the best and most effective use of blood glucose monitoring for diabetes and that because the current primary care trust guidelines discourage the prescription of blood glucose strips for...
That this House notes the severe illness and deaths of haemophiliacs and some partners from HIV and hepatitis C, caused by the use of contaminated blood products and the potential for future deaths from vCJD; and supports the Haemophilia Society in its calls for an independent public inquiry into the contamination of haemophilia treatment since the 1970s, in particular the failure to make the UK self-sufficient in blood products, the failure in some parts of the UK to make a timely switch to virally inactivated treatment when this became available from 1985 and the failure to make timely provision of genetically-engineered recombinant Factor VIII and IX for all haemophiliacs.
That this House notes the severe illness and deaths of haemophiliacs and some partners from HIV and hepatitis C, caused by the use of contaminated blood products and the potential for future deaths from vCJD; and supports the Haemophilia Society in its calls for an independent public inquiry into the...
That this House notes the severe illness and deaths of haemophiliacs and some partners from HIV and hepatitis C, caused by the use of contaminated blood products, and the potential for future deaths from vCJD; and supports the Haemophilia Society in its call for an independent public inquiry into the contamination of haemophilia treatment since the 1970s, in particular the failure to make the UK self-sufficient in blood products, the failure in some parts of the UK to make a timely switch to virally inactivated treatment when this became available from 1985 and the failure to make timely provision of genetically-engineered recombinant Factor VIII and IX for all haemophiliacs.
That this House notes the severe illness and deaths of haemophiliacs and some partners from HIV and hepatitis C, caused by the use of contaminated blood products, and the potential for future deaths from vCJD; and supports the Haemophilia Society in its call for an independent public inquiry into the...
That this House recognises the special nature of voluntary blood donoring in the United Kingdom, the excellent work of the Blood Donor Service and the worthy, generous and thoughtful dedication of the blood donors themselves to whom so many owe their lives; regrets that hospitals, which rely on the selfless help of blood donors to do their work, are now charging blood donors sums such as ??25 for information to prove that the blood donor is eligible to give blood and that this practice, essentially making a charge on blood donors, is annoying and discouraging blood donors; and calls on the Government to stop this practice.
That this House recognises the special nature of voluntary blood donoring in the United Kingdom, the excellent work of the Blood Donor Service and the worthy, generous and thoughtful dedication of the blood donors themselves to whom so many owe their lives; regrets that hospitals, which rely on the selfless...
That this House notes that approximately 1.5 per cent. of the population require oral anticoagulation therapy; recognises that hospital warfarin clinics consume substantial resources with time and travel implications for patients; further notes that new hand-held coagulometers can be used by patients in their own homes, simplifying monitoring particularly in elderly and confused patients; is aware that these new coagulometers have been provided elsewhere including to approximately 100,000 patients in Germany, yet in Northern Ireland are only acquired privately or through fundraising efforts; and seeks an extensive appraisal of whether making this less invasive form of INR monitoring more widely available through the NHS could not only benefit and empower patients but save the health service time and money.
That this House notes that approximately 1.5 per cent. of the population require oral anticoagulation therapy; recognises that hospital warfarin clinics consume substantial resources with time and travel implications for patients; further notes that new hand-held coagulometers can be used by patients in their own homes, simplifying monitoring particularly in...
To ask the Secretary of State for Health, how many recipients of (a) blood and (b) blood products derived from donors who subsequently were confirmed to have variant Creutzfeldt-Jakob Disease have been identified.
To ask the Secretary of State for Health, how many recipients of (a) blood and (b) blood products derived from donors who subsequently were confirmed to have variant Creutzfeldt-Jakob Disease have been identified.
To ask the Secretary of State for Health, how many haemophiliacs in the United Kingdom have been treated in each year since 1975 for (a) hepatitis C and (b) CJD acquired from contaminated blood products. - Not available centrally.
To ask the Secretary of State for Health, how many haemophiliacs in the United Kingdom have been treated in each year since 1975 for (a) hepatitis C and (b) CJD acquired from contaminated blood products. - Not available centrally.
To ask the Secretary of State for Health, how many haemophiliacs died from blood product acquired infections in each year from 1975 to 1987. - Inc table and ref to 5 January 2004, 416 c191-2W.
To ask the Secretary of State for Health, how many haemophiliacs died from blood product acquired infections in each year from 1975 to 1987. - Inc table and ref to 5 January 2004, 416 c191-2W.
To ask the Secretary of State for Health, pursuant to his oral statement of 17th December 2003, 415 c1571, what assessment he has made of the state of health of the second recipient of blood from the donor who later died of variant Creutzfeldt-Jakob Disease.
To ask the Secretary of State for Health, pursuant to his oral statement of 17th December 2003, 415 c1571, what assessment he has made of the state of health of the second recipient of blood from the donor who later died of variant Creutzfeldt-Jakob Disease.
To ask the Secretary of State for Health, pursuant to his oral statement of 17th December 2003, 415 c1571, what assessment he has made of the likelihood of the donor and the recipient of variant Creutzfeldt-Jakob Disease infected blood having independently contracted variant Creutzfeldt-Jakob Disease.
To ask the Secretary of State for Health, pursuant to his oral statement of 17th December 2003, 415 c1571, what assessment he has made of the likelihood of the donor and the recipient of variant Creutzfeldt-Jakob Disease infected blood having independently contracted variant Creutzfeldt-Jakob Disease.
To ask the Secretary of State for Health, how many recipients of blood products have died of variant Creutzfeldt-Jakob Disease since 1993. - Inc figures.
To ask the Secretary of State for Health, how many recipients of blood products have died of variant Creutzfeldt-Jakob Disease since 1993. - Inc figures.
To ask the Secretary of State for Health, what statistics his Department collates on the incidence of blood-borne diseases in recipients of blood products; and if he will make a statement. - ot available centrally.
To ask the Secretary of State for Health, what statistics his Department collates on the incidence of blood-borne diseases in recipients of blood products; and if he will make a statement. - ot available centrally.
To ask the Secretary of State for Health, what assessment he has made of the (a) methodology and (b) effectiveness of screening for infections of (i) blood products and (ii) whole blood to be used by the NHS; and if he will make a statement; what assessment he has made...
To ask the Secretary of State for Health, what assessment he has made of the (a) methodology and (b) effectiveness of screening for infections of (i) blood products and (ii) whole blood to be used by the NHS; and if he will make a statement; what assessment he has made...
To ask the Secretary of State for Health, when blood testing for contaminated blood product-induced infections was started (a) with consent and (b) without consent; and if he will make a statement. - Including ref to www.doh.gov.uk/consent.
To ask the Secretary of State for Health, when blood testing for contaminated blood product-induced infections was started (a) with consent and (b) without consent; and if he will make a statement. - Including ref to www.doh.gov.uk/consent.
To ask the Secretary of State for Health, what assessment he has made of the risk of possible infection with variant Creutzfeldt-Jakob Disease from large pools of plasma; and what the likely effects are of dilution of infected blood products in large pools.
To ask the Secretary of State for Health, what assessment he has made of the risk of possible infection with variant Creutzfeldt-Jakob Disease from large pools of plasma; and what the likely effects are of dilution of infected blood products in large pools.
To ask the Secretary of State for Health, what steps his Department takes to trace recipients of blood donated by donors identified as having (a) variant Creutzfeldt-Jakob Disease and (b) other blood-borne diseases.
To ask the Secretary of State for Health, what steps his Department takes to trace recipients of blood donated by donors identified as having (a) variant Creutzfeldt-Jakob Disease and (b) other blood-borne diseases.
To ask the Secretary of State for Health, how many haemophiliacs were diagnosed in each year since 1975; how many haemophiliacs died from blood product acquired infections in each year since 1975; how many haemophiliacs in the UK have been treated in each year since 1975 for (a) HIV, (b)...
To ask the Secretary of State for Health, how many haemophiliacs were diagnosed in each year since 1975; how many haemophiliacs died from blood product acquired infections in each year since 1975; how many haemophiliacs in the UK have been treated in each year since 1975 for (a) HIV, (b)...